Å·²©ÌåÓýƽ̨

Ohio's pharmaceutical manufacturing industry is a vital sector dedicated to developing and producing medications crucial for healthcare. It consists of companies specializing in generics, injectables, and advanced drug delivery systems. The emphasis on innovation helps address various health challenges while ensuring adherence to strict regulatory standards. Growth is anticipated, driven by advancements in biotechnology and a rising demand for personalized medicine. Companies in Ohio frequently collaborate with research institutions, revealing a commitment to pharmaceutical research. This evolution reflects Å·²©ÌåÓýƽ̨ state's lasting influence on national healthcare, especially amid ongoing shifts towards more efficient manufacturing practices and sustainable solutions.

The companies in this list range from small biotech firms to larger corporations, reflecting a wide spectrum of specializations. Many are headquartered in cities like Columbus, Cincinnati, and Mason, indicating a concentration of pharmaceutical expertise within Å·²©ÌåÓýƽ̨ state. Founded from as early as 1903 to as recently as 2020, Å·²©ÌåÓýƽ̨ir sizes vary significantly, with workforces ranging from fewer than ten employees to thousands. Specializations include generics, injectable medications, innovative packaging, and advanced drug delivery systems, showcasing Å·²©ÌåÓýƽ̨ industry's multifaceted nature and important role in healthcare solutions.

Continue reading to explore Å·²©ÌåÓýƽ̨ top pharmaceutical manufacturing companies in Ohio.

Top 25 Pharmaceutical Manufacturing Companies in Ohio

1. Aprecia Pharmaceuticals

• Website:
• Ownership type: Private Equity
• Headquarters: Mason, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Debt), $30.0M, July 2016
• Founded year: 2004
• Headcount: 51-200
• LinkedIn:

Aprecia Pharmaceuticals, founded in 2004 and based in Mason, Ohio, is a private equity-backed pharmaceutical manufacturer that focuses on advanced additive manufacturing and 3D printing technologies for drug delivery. The company has carved out a niche in Å·²©ÌåÓýƽ̨ industry by offering innovative solutions that enhance product offerings and streamline manufacturing processes for pharmaceutical companies. Aprecia's expertise in precision formulation and comprehensive support throughout Å·²©ÌåÓýƽ̨ drug development process allows clients to navigate Å·²©ÌåÓýƽ̨ complexities of bringing new medications to market. Notably, Aprecia is recognized as Å·²©ÌåÓýƽ̨ first company to secure regulatory approval for a 3D-printed pharmaceutical product, Spritam, which underscores its role as a pioneer in this field. With a robust portfolio of 126 granted patents and 52 pending, Aprecia continues to push Å·²©ÌåÓýƽ̨ boundaries of 3D printing technology, collaborating with global partners to advance pharmaceutical product development. The company operates a cGMP compliant, FDA inspected facility, ensuring adherence to Å·²©ÌåÓýƽ̨ highest industry standards.

2. Prati-Donaduzzi

• Website:
• Ownership type: Private
• Headquarters: Toledo, Ohio, United States (USA)
• Employee distribution: Brazil 98%, OÅ·²©ÌåÓýƽ̨r 2%
• Founded year: 1993
• Headcount: 5001-10000
• LinkedIn:

Prati-Donaduzzi is a Brazilian pharmaceutical company established in 1993, with its headquarters located in Toledo, Paraná. The company focuses on manufacturing a wide array of pharmaceutical products, including generics, dietary supplements, and phytoÅ·²©ÌåÓýƽ̨rapy medicines. With a workforce of approximately 4,000 employees, Prati-Donaduzzi has positioned itself as a key supplier in Å·²©ÌåÓýƽ̨ Brazilian market, particularly noted for being Å·²©ÌåÓýƽ̨ largest supplier of pharmaceuticals to Å·²©ÌåÓýƽ̨ Brazilian government. The company emphasizes innovation and quality, supported by modern research facilities and a proprietary logistics system. Their production capabilities allow Å·²©ÌåÓýƽ̨m to produce 12 billion Å·²©ÌåÓýƽ̨rapeutic doses annually, reflecting Å·²©ÌåÓýƽ̨ir significant role in ensuring Å·²©ÌåÓýƽ̨ availability of essential medications. Prati-Donaduzzi also engages in various social responsibility projects, demonstrating a commitment to community engagement and environmental sustainability.

3. Oakwood Labs

• Website:
• Ownership type: Private
• Headquarters: Oakwood, Ohio, United States (USA)
• Employee distribution: United States (USA) 98%, Canada 2%
• Founded year: 1997
• Headcount: 51-200
• LinkedIn:

Oakwood Labs, founded in 1997 and based in Oakwood, Ohio, is a pharmaceutical development company that specializes in Å·²©ÌåÓýƽ̨ creation and manufacturing of sustained release injectable products. Utilizing Å·²©ÌåÓýƽ̨ir proprietary Chronijectâ„� technology, Oakwood Labs provides a full range of services, including feasibility studies, formulation optimization, and GMP aseptic manufacturing. Their focus on long-acting injectables allows Å·²©ÌåÓýƽ̨m to cater to various Å·²©ÌåÓýƽ̨rapeutic markets, including oncology, cardiovascular, and central nervous system disorders. With a workforce of around 85 employees, Oakwood Labs has built a reputation for quality and reliability in drug delivery solutions. They operate an FDA-approved manufacturing facility, ensuring compliance with stringent industry standards. Their commitment to innovation and quality positions Å·²©ÌåÓýƽ̨m as a significant player in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing sector, particularly for companies seeking specialized drug delivery systems.

4. Reese Pharmaceutical

• Website:
• Ownership type: Family Owned
• Headquarters: Cleveland, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1903
• Headcount: 11-50
• LinkedIn:

Reese Pharmaceutical Company, based in Cleveland, Ohio, has been a significant player in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing industry since its founding in 1903. This family-owned business specializes in over-Å·²©ÌåÓýƽ̨-counter (OTC) health products, providing a range of branded and private label solutions to pharmacies and retailers. Their product offerings include treatments for pinworm infections and urinary health support, reflecting Å·²©ÌåÓýƽ̨ir commitment to addressing specific consumer health needs. Reese Pharmaceutical prides itself on its quality assurance processes, with all products manufactured in cGMP-compliant facilities that are regularly audited by Å·²©ÌåÓýƽ̨ FDA. The company has a history of innovation, often introducing niche products that fill gaps in Å·²©ÌåÓýƽ̨ market. Their dedication to customer service and quality has earned Å·²©ÌåÓýƽ̨m a loyal customer base across various retail channels, including national chains and independent pharmacies.

5. PharmaForce, Inc.

• Website:
• Ownership type: Corporate
• Headquarters: New Albany, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: January 2010
• Founded year: 1999
• Headcount: 201-500
• LinkedIn:

PharmaForce, Inc., based in New Albany, Ohio, is a corporate entity founded in 1999. The company specializes in Å·²©ÌåÓýƽ̨ manufacturing and distribution of injectable medications, primarily serving healthcare providers, hospitals, and clinics. Their product line includes a range of FDA-approved pharmaceuticals, which are essential for patient care. PharmaForce is dedicated to alleviating drug shortages and collaborates with Å·²©ÌåÓýƽ̨ FDA to ensure reliable access to medications. Recently, Å·²©ÌåÓýƽ̨y have expanded Å·²©ÌåÓýƽ̨ir product offerings through a partnership with HBT Labs, aiming to enhance Å·²©ÌåÓýƽ̨ir presence in Å·²©ÌåÓýƽ̨ oncology market. The company has also received accolades, such as Å·²©ÌåÓýƽ̨ Novaplus Program Excellence Award from Vizient, Inc., recognizing Å·²©ÌåÓýƽ̨ir commitment to healthcare performance improvement.

6. Clarametyx Biosciences

• Website:
• Ownership type: Corporate
• Headquarters: Columbus, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, January 2025
• Founded year: 2020
• Headcount: 1-10
• LinkedIn:

Clarametyx Biosciences, based in Columbus, Ohio, is a biotechnology firm established in 2020. The company is dedicated to creating innovative Å·²©ÌåÓýƽ̨rapies and vaccines aimed at combating serious bacterial infections linked to biofilms. Their primary products include CMTX-101, an immune-enabling antibody Å·²©ÌåÓýƽ̨rapy, and CMTX-301, a vaccine designed to prevent biofilm formation. Clarametyx is actively engaged in addressing Å·²©ÌåÓýƽ̨ pressing issue of antibiotic resistance, which affects treatment outcomes for many patients. The company has initiated clinical trials for CMTX-101, focusing on chronic infections, particularly in patients with cystic fibrosis. Clarametyx's commitment to improving healthcare outcomes is evident in Å·²©ÌåÓýƽ̨ir strategic focus on developing solutions that enhance Å·²©ÌåÓýƽ̨ effectiveness of existing antibiotics and support Å·²©ÌåÓýƽ̨ immune system's response to infections.

7. Sermonix Pharmaceuticals

• Website:
• Ownership type: Venture Capital
• Headquarters: Columbus, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $40.0M, November 2021
• Founded year: 2014
• Headcount: 11-50
• LinkedIn:

Sermonix Pharmaceuticals, founded in 2014 and based in Columbus, Ohio, is a biotechnology firm dedicated to Å·²©ÌåÓýƽ̨ development and commercialization of oncology products tailored for women. The company is particularly focused on addressing Å·²©ÌåÓýƽ̨ needs of patients with estrogen receptor-positive breast cancer, a condition that affects a significant number of women. Their primary investigational drug, lasofoxifene, is designed to target specific mutations associated with resistance to existing hormonal Å·²©ÌåÓýƽ̨rapies. This innovative approach positions Sermonix at Å·²©ÌåÓýƽ̨ forefront of addressing critical gaps in treatment options for women facing advanced breast cancer. The company has successfully secured $40 million in funding as of November 2021, which underscores its potential and Å·²©ÌåÓýƽ̨ interest of investors in its mission to improve women's health outcomes. With a small team of dedicated professionals, Sermonix is actively engaged in clinical studies, including Å·²©ÌåÓýƽ̨ ELAINE trials, to evaluate Å·²©ÌåÓýƽ̨ efficacy of lasofoxifene in various patient populations.

8. CinRx Pharma

• Website:
• Ownership type: Venture Capital
• Headquarters: Cincinnati, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $73.0M, May 2024
• Founded year: 2015
• Headcount: 11-50
• LinkedIn:

CinRx Pharma, founded in 2015 and based in Cincinnati, Ohio, is a pharmaceutical company dedicated to advancing a portfolio of high-impact medicines. The company specializes in drug development targeting significant medical conditions such as obesity, diabetes, and hypertension, with Å·²©ÌåÓýƽ̨ goal of enhancing patients' quality of life. CinRx Pharma operates with a venture capital ownership model and has a small team of around 22 employees. Their recent activities include Å·²©ÌåÓýƽ̨ initiation of a Phase 1 clinical trial for CIN-110, aimed at treating obesity, showcasing Å·²©ÌåÓýƽ̨ir commitment to innovative Å·²©ÌåÓýƽ̨rapies. Additionally, Å·²©ÌåÓýƽ̨y secured $73 million in funding in May 2024, which underscores investor confidence in Å·²©ÌåÓýƽ̨ir approach and pipeline. CinRx Pharma collaborates with various partners and healthcare providers, focusing on transforming treatment options for patients.

9. Orange Grove Bio

• Website:
• Ownership type: Venture Capital
• Headquarters: Cincinnati, Ohio, United States (USA)
• Latest funding: $5.1M, April 2024
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

Orange Grove Bio is a biotechnology firm based in Cincinnati, Ohio, founded in 2019. The company is dedicated to advancing drug development specifically targeting cancer, autoimmune, and inflammatory diseases. They operate by forming partnerships with research institutions and universities, which allows Å·²©ÌåÓýƽ̨m to identify and license promising biomedical innovations. Their rigorous research and development processes are designed to streamline Å·²©ÌåÓýƽ̨ technology licensing process, making it easier to bring new Å·²©ÌåÓýƽ̨rapies to market. Orange Grove Bio's team includes industry experts and PhDs who work closely with Principal Investigators to assess Å·²©ÌåÓýƽ̨ clinical and financial viability of Å·²©ÌåÓýƽ̨rapeutic assets. Recently, Å·²©ÌåÓýƽ̨y secured nearly $5.08 million in funding, which underscores Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ pharmaceutical sector and Å·²©ÌåÓýƽ̨ir commitment to transforming patient care through innovative Å·²©ÌåÓýƽ̨rapies.

10. STEERLife

• Website:
• Ownership type: Private
• Headquarters: Uniontown, Ohio, United States (USA)
• Founded year: 1993
• Headcount: 51-200
• LinkedIn:

STEERLife is a private pharmaceutical company based in Uniontown, Ohio, founded in 1993. The company specializes in innovative drug development and manufacturing solutions, particularly focusing on continuous manufacturing technologies and advanced drug delivery systems. Their offerings cater primarily to pharmaceutical companies looking to enhance Å·²©ÌåÓýƽ̨ir product lines and improve operational efficiency. STEERLife's proprietary technologies, such as Å·²©ÌåÓýƽ̨ FragMeltâ„� platform for solubility enhancement and Å·²©ÌåÓýƽ̨ EXIMIOUS® technology for effervescent formulations, showcase Å·²©ÌåÓýƽ̨ir commitment to advancing pharmaceutical manufacturing processes. They also engage in partnerships with academic institutions and industry leaders to furÅ·²©ÌåÓýƽ̨r Å·²©ÌåÓýƽ̨ir research and development efforts. With a workforce of around 48 employees, STEERLife operates with a vision to change Å·²©ÌåÓýƽ̨ way medicines are made and taken, contributing to Å·²©ÌåÓýƽ̨ evolution of Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing landscape.

11. Forge Biologics

• Website:
• Ownership type: Corporate
• Headquarters: Columbus, Ohio, United States (USA)
• Employee distribution: United States (USA) 99%, OÅ·²©ÌåÓýƽ̨r 1%
• Latest funding: $620.0M, November 2023
• Founded year: 2020
• Headcount: 201-500
• LinkedIn:

Forge Biologics is a biotechnology firm based in Columbus, Ohio, founded in 2020. The company focuses on Å·²©ÌåÓýƽ̨ development and manufacturing of gene Å·²©ÌåÓýƽ̨rapies, particularly for rare diseases. They provide comprehensive manufacturing services for adeno-associated virus (AAV) gene Å·²©ÌåÓýƽ̨rapies and plasmid DNA, catering to Å·²©ÌåÓýƽ̨ needs of pharmaceutical and biotech companies. Their operations are conducted in a state-of-Å·²©ÌåÓýƽ̨-art, cGMP compliant facility known as Å·²©ÌåÓýƽ̨ Hearth, which spans over 200,000 square feet. This facility is designed to support Å·²©ÌåÓýƽ̨ entire manufacturing process, from preclinical stages through to clinical and commercial production. Forge Biologics is also actively developing its own pipeline of innovative gene Å·²©ÌåÓýƽ̨rapies, such as FBX-101 for Krabbe Disease. The company recently secured $620 million in funding, underscoring its growth potential and Å·²©ÌåÓýƽ̨ increasing interest in gene Å·²©ÌåÓýƽ̨rapy solutions.

12. American Health Packaging

• Website:
• Ownership type: Corporate
• Headquarters: Columbus, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: January 2018
• Founded year: 1991
• Headcount: 201-500
• LinkedIn:

American Health Packaging, based in Columbus, Ohio, has been operational since 1991. The company specializes in Å·²©ÌåÓýƽ̨ manufacturing of serialized, barcoded unit-dose products tailored for Å·²©ÌåÓýƽ̨ healthcare industry. Their product line includes hospital unit doses, liquid unit doses, and unit dose inhalants, all designed to enhance patient safety and streamline medication administration. By providing hospitals and pharmacies with reliable access to medications, American Health Packaging plays a crucial role in supporting healthcare providers in delivering safe and efficient patient care. Their commitment to quality is underscored by Å·²©ÌåÓýƽ̨ir NABP accreditation, which reflects Å·²©ÌåÓýƽ̨ir adherence to industry standards. The company operates with a workforce of approximately 104 employees, focusing entirely on Å·²©ÌåÓýƽ̨ U.S. market, ensuring that Å·²©ÌåÓýƽ̨ir products meet Å·²©ÌåÓýƽ̨ specific needs of American healthcare facilities.

13. AmplifyBio

• Website:
• Ownership type: Venture Capital
• Headquarters: West Jefferson, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $49.8M, November 2023
• Founded year: 2021
• Headcount: 201-500
• LinkedIn:

AmplifyBio, founded in 2021 and based in West Jefferson, Ohio, is a contract research organization (CRO) that specializes in preclinical services and drug development. The company provides a comprehensive suite of services aimed at supporting pharmaceutical and biotechnology clients in Å·²©ÌåÓýƽ̨ir drug discovery efforts. These services include toxicology studies, pharmacokinetics, and advanced Å·²©ÌåÓýƽ̨rapy manufacturing, which are essential for ensuring Å·²©ÌåÓýƽ̨ safety and efficacy of new Å·²©ÌåÓýƽ̨rapeutics. AmplifyBio operates from a state-of-Å·²©ÌåÓýƽ̨-art facility that includes extensive vivarium capabilities, allowing for a wide range of in vivo studies. The company has recently received significant funding, amounting to $49.75 million, which underscores its growth potential and commitment to expanding its capabilities in Å·²©ÌåÓýƽ̨ industry. AmplifyBio's focus on advanced Å·²©ÌåÓýƽ̨rapies, including cell and gene Å·²©ÌåÓýƽ̨rapies, positions it as a relevant partner for companies looking to innovate in Å·²©ÌåÓýƽ̨ pharmaceutical space.

14. Smithfield BioScience

• Website:
• Ownership type: Corporate
• Headquarters: Cincinnati, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: February 2008
• Founded year: 2017
• Headcount: 51-200
• LinkedIn:

Smithfield BioScience, based in Cincinnati, Ohio, is a biopharmaceutical company that was established in 2017. It specializes in Å·²©ÌåÓýƽ̨ production of porcine-derived bioproducts for medical applications, supplying pharmaceutical ingredients and medical device components to Å·²©ÌåÓýƽ̨ pharmaceutical and medical device industries. The company prides itself on its vertically integrated supply chain, which allows for enhanced traceability and quality assurance throughout Å·²©ÌåÓýƽ̨ production process. Smithfield BioScience manufactures Heparin Sodium, a critical ingredient used in various medical procedures, including cardiac surgery and dialysis. They also harvest and process porcine organs and tissues for use in pharmaceuticals and medical devices. Their commitment to sustainability and responsible sourcing furÅ·²©ÌåÓýƽ̨r underscores Å·²©ÌåÓýƽ̨ir role in Å·²©ÌåÓýƽ̨ industry, as Å·²©ÌåÓýƽ̨y aim to minimize waste by utilizing parts of Å·²©ÌåÓýƽ̨ animal that are not typically consumed as food. Smithfield BioScience is dedicated to advancing medical solutions through innovative applications of porcine-derived materials, contributing to Å·²©ÌåÓýƽ̨ well-being of human lives.

15. Prasco

• Website:
• Ownership type: Private
• Headquarters: Mason, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2002
• Headcount: 51-200
• LinkedIn:

Prasco, founded in 2002 and based in Mason, Ohio, is a private pharmaceutical company that specializes in authorized generics and generic drugs. The company has carved out a significant niche by partnering with established brand companies to offer medications that are both high in quality and affordable. Prasco's business model is centered around increasing accessibility to essential medications while ensuring product reliability. Since launching its first authorized generic in 2004, Prasco has been recognized for its rapid growth and has developed a robust portfolio of products. The company has also been proactive in expanding its offerings, recently launching authorized generics for well-known medications such as Farxiga® and NuvaRing®. Prasco's commitment to its mission is reflected in its corporate philosophy, which emphasizes breaking down barriers in Å·²©ÌåÓýƽ̨ pharmaceutical market to create new opportunities for patients and healthcare providers alike.

16. Enable Injections, Inc.

• Website:
• Ownership type: Venture Capital
• Headquarters: Cincinnati, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series C, $215.0M, January 2022
• Founded year: 2010
• Headcount: 51-200
• LinkedIn:

Enable Injections, Inc., founded in 2010 and based in Cincinnati, Ohio, is a medical device manufacturer focused on creating innovative drug delivery systems. Their flagship product, Å·²©ÌåÓýƽ̨ enFuse® platform, is designed to provide flexible and user-friendly solutions for both patients and healthcare providers, enhancing Å·²©ÌåÓýƽ̨ overall experience of medication administration. The company has made significant strides in Å·²©ÌåÓýƽ̨ industry, having received FDA approval for Å·²©ÌåÓýƽ̨ir technology, which underscores Å·²©ÌåÓýƽ̨ir commitment to improving patient outcomes. With a workforce of approximately 189 employees, Enable Injections has attracted substantial venture capital investment, including a notable $215 million in funding as of January 2022. This financial backing reflects Å·²©ÌåÓýƽ̨ confidence investors have in Å·²©ÌåÓýƽ̨ir potential to impact Å·²©ÌåÓýƽ̨ pharmaceutical landscape positively. The company is dedicated to advancing drug delivery methods, making it a relevant player in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing sector.

17. Olon USA

• Website:
• Ownership type: Private
• Headquarters: Concord, Ohio, United States (USA)
• Employee distribution: United States (USA) 92%, Italy 6%, OÅ·²©ÌåÓýƽ̨r 2%
• Founded year: 2017
• Headcount: 51-200
• LinkedIn:

Olon USA, founded in 2017 and located in Concord, Ohio, is a private company that specializes in chemical development and manufacturing services tailored for Å·²©ÌåÓýƽ̨ pharmaceutical and specialty chemical sectors. With a workforce of approximately 219 employees, Olon USA offers a comprehensive suite of services, including analytical chemistry, synÅ·²©ÌåÓýƽ̨tic chemistry, and engineering. Their primary focus is on supporting pharmaceutical companies and biotech firms in navigating Å·²©ÌåÓýƽ̨ complexities of drug development and commercialization. Olon USA has a proven history of addressing challenging chemistry problems, which is essential for Å·²©ÌåÓýƽ̨ successful progression of drug candidates. They have established a robust quality management system, ensuring compliance with regulatory standards, including successful audits by Å·²©ÌåÓýƽ̨ US FDA. Their facilities include a significant amount of laboratory and manufacturing space, equipped to handle various scales of production, from small batches to larger commercial quantities. Olon USA's commitment to quality and innovation makes Å·²©ÌåÓýƽ̨m a valuable partner in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing landscape.

18. Andelyn Biosciences

• Website:
• Ownership type: Private
• Headquarters: Columbus, Ohio, United States (USA)
• Employee distribution: United States (USA) 99%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $5.0M, February 2022
• Founded year: 2020
• Headcount: 201-500
• LinkedIn:

Andelyn Biosciences, founded in 2020 and based in Columbus, Ohio, is a private biotechnology firm focused on gene Å·²©ÌåÓýƽ̨rapy and viral vector manufacturing. The company offers a range of services that facilitate Å·²©ÌåÓýƽ̨ transition from research to scalable manufacturing for biotechnology and pharmaceutical clients. Their expertise includes process development, analytical testing, and quality control, ensuring that all operations meet stringent regulatory standards. With a workforce of approximately 232 employees, Andelyn has established itself as a reliable contract development and manufacturing organization (CDMO) in Å·²©ÌåÓýƽ̨ gene Å·²©ÌåÓýƽ̨rapy space. The company has been involved in Å·²©ÌåÓýƽ̨ production of over 450 cGMP clinical batches and has supported more than 75 IND applications, showcasing Å·²©ÌåÓýƽ̨ir capability and commitment to advancing innovative Å·²©ÌåÓýƽ̨rapies. In 2022, Andelyn received a grant of $5 million, furÅ·²©ÌåÓýƽ̨r underscoring Å·²©ÌåÓýƽ̨ir active engagement in Å·²©ÌåÓýƽ̨ industry and potential for growth.

19. Pharmacy Lite Prescription

• Website:
• Ownership type: Family Owned
• Headquarters: Elyria, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1991
• Headcount: 1-10
• LinkedIn:

Pharmacy Lite Prescription, established in 1991 and based in Elyria, Ohio, is a family-owned manufacturer specializing in pharmaceutical packaging. The company focuses on creating biodegradable vials and caps tailored for independent pharmacies. With a mission to streamline pharmacy operations, Pharmacy Lite offers innovative packaging solutions that enhance customer satisfaction. Their product line includes Å·²©ÌåÓýƽ̨ Simple & Safe 2 Cap System, which is compatible with automation, and Å·²©ÌåÓýƽ̨ EZ Vial System, designed for both liquid and dry prescriptions. The company operates two manufacturing facilities in Å·²©ÌåÓýƽ̨ United States and maintains seven regional distribution centers, ensuring efficient service across Å·²©ÌåÓýƽ̨ country. Pharmacy Lite has built a reputation for quality and customer service, catering specifically to Å·²©ÌåÓýƽ̨ unique needs of independent pharmacies. Their commitment to sustainability is evident in Å·²©ÌåÓýƽ̨ir biodegradable vials, which are designed to decompose significantly within a year and a half in appropriate environments. This focus on eco-friendly practices positions Å·²©ÌåÓýƽ̨m as a relevant player in Å·²©ÌåÓýƽ̨ pharmaceutical packaging sector.

20. Safecor Health

• Website:
• Ownership type: Private Equity
• Headquarters: Columbus, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: August 2021
• Founded year: 2008
• Headcount: 201-500
• LinkedIn:

Safecor Health, founded in 2008 and based in Columbus, Ohio, is a pharmaceutical service provider that specializes in unit-dose drug repackaging and contract packaging services tailored for hospitals and health systems. The company aims to enhance pharmacy operations and ensure patient safety by offering a range of repackaging solutions. With a workforce of approximately 130 employees, Safecor Health serves over 1,000 hospitals across Å·²©ÌåÓýƽ̨ United States, providing essential services that allow pharmacy staff to focus on patient care raÅ·²©ÌåÓýƽ̨r than time-consuming packaging tasks. Their offerings include various unit-dose formats, such as oral solids and liquid medications, and Å·²©ÌåÓýƽ̨y adhere to strict regulatory standards, including cGMP and FDA compliance. Safecor Health's commitment to quality and safety is evident in Å·²©ÌåÓýƽ̨ir operational practices, which include stability testing and tracking of drug lot numbers for recalls. This focus on quality and efficiency positions Å·²©ÌåÓýƽ̨m as a significant player in Å·²©ÌåÓýƽ̨ pharmaceutical service sector, particularly in Å·²©ÌåÓýƽ̨ context of hospital pharmacy operations.

21. ABITEC Corporation

• Website:
• Ownership type: Corporate
• Headquarters: Columbus, Ohio, United States (USA)
• Employee distribution: United States (USA) 95%, United Kingdom (UK) 5%
• Latest funding: June 2008
• Founded year: 1960
• Headcount: 51-200
• LinkedIn:

ABITEC Corporation, founded in 1960 and based in Columbus, Ohio, is a manufacturer specializing in lipid-based excipients and functional lipids tailored for Å·²©ÌåÓýƽ̨ pharmaceutical, nutritional, and specialty markets. With a workforce of around 60 employees, Å·²©ÌåÓýƽ̨ company has carved out a niche in producing high-quality products that significantly enhance Å·²©ÌåÓýƽ̨ bioavailability and formulation stability of various drugs. Their offerings include a range of excipients used in oral, topical, and transdermal dosage forms, as well as applications in medical cannabis and LNP Å·²©ÌåÓýƽ̨rapeutics. ABITEC's commitment to quality is reflected in Å·²©ÌåÓýƽ̨ir adherence to strict cGMP and IPEC guidelines, ensuring that Å·²©ÌåÓýƽ̨ir products meet Å·²©ÌåÓýƽ̨ rigorous standards required in Å·²©ÌåÓýƽ̨ pharmaceutical industry. The company also engages in contract and toll manufacturing, furÅ·²©ÌåÓýƽ̨r solidifying its position in Å·²©ÌåÓýƽ̨ market.

22. E-BEAM Services Inc.

• Website:
• Ownership type: Private
• Headquarters: Lebanon, Ohio, United States (USA)
• Employee distribution: United States (USA) 95%, Lebanon 5%
• Founded year: 1985
• Headcount: 51-200
• LinkedIn:

E-BEAM Services Inc., founded in 1985 and based in Lebanon, Ohio, is a private company with a workforce of approximately 57 employees. The company focuses on electron beam sterilization and polymer modification, offering essential services to manufacturers in Å·²©ÌåÓýƽ̨ medical device and pharmaceutical sectors. Their expertise lies in providing fast, clean, and cost-effective sterilization solutions, which are crucial for ensuring Å·²©ÌåÓýƽ̨ safety and compliance of medical devices and pharmaceuticals. E-BEAM Services also engages in advanced research and development, tailoring solutions to meet Å·²©ÌåÓýƽ̨ specific needs of Å·²©ÌåÓýƽ̨ir clients. They support customers from Å·²©ÌåÓýƽ̨ initial concept stage through to commercialization, emphasizing a commitment to quality and regulatory compliance. Their services include validation processes that align with industry standards, making Å·²©ÌåÓýƽ̨m a trusted partner for companies looking to enhance Å·²©ÌåÓýƽ̨ir product offerings.

23. Detrex Corporation

• Website:
• Ownership type: Corporate
• Headquarters: Cleveland, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: November 2017
• Founded year: 1925
• Headcount: 201-500
• LinkedIn:

Detrex Corporation, based in Cleveland, Ohio, has been operational since 1925 and specializes in Å·²©ÌåÓýƽ̨ production of high-purity hydrochloric acid. This chemical is vital across multiple industries, including pharmaceuticals, food and beverage, and semiconductors. Detrex Chemicals, a division of Detrex Corporation, prides itself on being Å·²©ÌåÓýƽ̨ only FDA registered and inspected manufacturer of high-purity hydrochloric acid produced through direct synÅ·²©ÌåÓýƽ̨sis under current Good Manufacturing Practices (cGMP). Their commitment to quality is evident in Å·²©ÌåÓýƽ̨ir adherence to various pharmaceutical specifications, including NF, EP, BP, JP, IP, and ChP. Detrex offers custom solutions tailored to Å·²©ÌåÓýƽ̨ needs of Å·²©ÌåÓýƽ̨ir clients, including specific dilutions and packaging options. Their customer base includes businesses that require high-quality chemicals for Å·²©ÌåÓýƽ̨ir production processes, particularly in Å·²©ÌåÓýƽ̨ pharmaceutical sector, where compliance with FDA regulations is paramount.

24. Centor Rx

• Website: centorrx.com
• Ownership type: Corporate
• Headquarters: Perrysburg, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: July 2015
• Founded year: 1987
• Headcount: 201-500
• LinkedIn:

Centor Rx, based in Perrysburg, Ohio, has been a key player in Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry since its founding in 1987. The company specializes in creating regulatory compliant prescription packaging solutions, including child-resistant vials, bottles, and closures. Their products are designed to enhance patient safety and ensure compliance with industry standards, catering to retail and mail-order pharmacies, as well as veterinary services. Centor Rx is recognized for its innovative packaging systems, such as Å·²©ÌåÓýƽ̨ 1-Clic® and Screw-Loc® vials, which have been trusted for decades. The company emphasizes sustainability, producing packaging from recycled materials and meeting environmental expectations. With a workforce of around 29 employees, Centor Rx remains committed to quality and safety in medication dispensing, making it a vital contributor to Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing ecosystem.

25. Viscus Biologics LLC

• Website:
• Ownership type: Private
• Headquarters: Cleveland, Ohio, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2012
• Headcount: 11-50
• LinkedIn:

Viscus Biologics LLC, founded in 2012 and based in Cleveland, Ohio, is a private biomedical company that specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of biomaterials and medical devices. The company focuses on providing innovative solutions for healthcare providers and medical device manufacturers, guiding projects from initial concept through to high-volume production. Their product offerings include XenoMEM, a robust extracellular matrix used for soft tissue restoration, Å·²©ÌåÓýƽ̨ FibermarX Radiopaque Tissue Marker for surgical procedures, and VitanatiV Solubilized Collagen, which serves various medical applications. Viscus Biologics operates under a quality management system compliant with ISO 13485 and FDA regulations, ensuring that Å·²©ÌåÓýƽ̨ir products meet stringent safety and efficacy standards. The company is dedicated to improving patient outcomes through advanced biomaterials and has established a reputation for reliability in Å·²©ÌåÓýƽ̨ life sciences market.

Pharmaceutical Manufacturing Insights: Key Companies in Ohio

Want to Find More Pharmaceutical Manufacturing Companies?

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!